Literature DB >> 8840744

Comprehensive pharmaceutical care in the chain setting.

J J Park1, P Kelly, B L Carter, P P Burgess.   

Abstract

A controlled, randomized study was conducted in two chain pharmacies to determine the clinical value of comprehensive pharmacy services for hypertensive patients in a chain pharmacy setting. Twenty-seven patients were enrolled as intervention participants with 26 control subjects. Monthly services for the intervention group included blood pressure and heart rate assessments and counseling on lifestyle modifications and drug therapy. Control patients received initial and final blood pressure measurements and minimal counseling. Both study and control groups completed quality-of-life questionnaires upon entering and completing the study. Results showed that blood pressure control was significantly improved in the study group. Compliance rates as well as energy/fatigue scores (a quality-of-life scale) improved in the study group compared with the control population. Community pharmacists in chain stores could have a beneficial effect on the health care of large numbers of patients if pharmaceutical care programs were developed.

Entities:  

Mesh:

Year:  1996        PMID: 8840744     DOI: 10.1016/s1086-5802(16)30099-7

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  38 in total

Review 1.  A review of the pharmacoeconomics of pharmaceutical care.

Authors:  R J Plumridge; R E Wojnar-Horton
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

Review 2.  Data collection methods for analyzing the quality of the dispensing in pharmacies.

Authors:  Francisco Caamaño; Alberto Ruano; Adolfo Figueiras; J J Gestal-Otero
Journal:  Pharm World Sci       Date:  2002-12

Review 3.  Pharmaceutical care programmes for the elderly: economic issues.

Authors:  Grainne E Crealey; Ian K Sturgess; James C McElnay; Carmel M Hughes
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 4.  A systematic review and meta-analysis of pharmacist-led fee-for-services medication review.

Authors:  Ernieda Hatah; Rhiannon Braund; June Tordoff; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

5.  Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries.

Authors:  C Bernsten; I Björkman; M Caramona; G Crealey; B Frøkjaer; E Grundberger; T Gustafsson; M Henman; H Herborg; C Hughes; J McElnay; M Magner; F van Mil; M Schaeffer; S Silva; B Søndergaard; I Sturgess; D Tromp; L Vivero; A Winterstein
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Engaging students in wellness and disease prevention services.

Authors:  Audra S Anderson; Jean-Venable R Goode
Journal:  Am J Pharm Educ       Date:  2006-04-15       Impact factor: 2.047

Review 7.  The effect of community pharmacy-based interventions on patient health outcomes: a systematic review.

Authors:  Susan J Blalock; Andrew W Roberts; Julie C Lauffenburger; Trey Thompson; Shanna K O'Connor
Journal:  Med Care Res Rev       Date:  2012-10-02       Impact factor: 3.929

8.  Description of pharmacist interventions during physician-pharmacist co-management of hypertension.

Authors:  Shannon J Von Muenster; Barry L Carter; Cynthia A Weber; Michael E Ernst; Jessica L Milchak; Jennifer J G Steffensmeier; Yinghui Xu
Journal:  Pharm World Sci       Date:  2007-08-21

Review 9.  The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ejaz Cheema; Paul Sutcliffe; Donald R J Singer
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

10.  Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial.

Authors:  N Yuksel; S R Majumdar; C Biggs; R T Tsuyuki
Journal:  Osteoporos Int       Date:  2009-06-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.